Activating Compound | Comment | Organism | Structure |
---|---|---|---|
additional information | p38 MAPK activation is required for recombinant activated protein C-mediated up-regulation of interleukin-10. Endothelial protein C receptor and protease-activated receptor-1 are required for the upregulation of interleukin-10 by recombinant activated protein C, whereas JRK 1495, JRK 1535, or ATAP-2 have no effect | Homo sapiens |
Application | Comment | Organism |
---|---|---|
medicine | recombinant activated protein C-mediated upregulation of interleukin-10 reduces tissue factor in circulating monocytes. Part of the protective effect of recombinant activated protein C therapy may reflect the ability of recombinant activated protein C to dampen the proinflammatory and procoagulant potential of activated monocytes | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
Phe-Pro-Arg-chloromethylketone | inhibits the active site of recombinant activated protein C | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | treatment of lipopolysaccharide-stimulated blood monocytes with recombinant activated protein C results in an upregulation of interleukin-10 protein production and mRNA synthesis and a downregulation of tissue factor Ag and activity levels. Serine protease activity is required for the upregulation of interleukin-10 by recombinant activated protein C | Homo sapiens | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
Activated protein C | - |
Homo sapiens |